Original language | English |
---|---|
Pages (from-to) | S942-S943 |
Journal | Arthritis and Rheumatism |
Volume | 58 |
Issue number | 9 |
Publication status | Published - Sept 2008 |
ACZ885 (canakinumab), a new II-1 beta blocking monoclonal antibody has a beneficial effect in children with systemic juvenile idiopathic arthritis (sjia)
Nicolino Ruperto, Pierre Quartier, Nico Wulffraat, Pat Woo, Anna Loy, Richard Mouy, Berent Prakken, Brigitte Bader-Meunier, Emanuele Noseda, Christiane Rordorf, Alberto Martini
Research output: Contribution to journal › Meeting Abstract › Academic